Impact of encorafenib on survival of patients with BRAFV600E-mutant metastatic colorectal cancer in a real-world setting.

Saved in:
Bibliographic Details
Title: Impact of encorafenib on survival of patients with BRAFV600E-mutant metastatic colorectal cancer in a real-world setting.
Authors: Zurloh, M.1,2 (AUTHOR), Goetz, M.3 (AUTHOR), Herold, T.2,3,4 (AUTHOR), Treckmann, J.2,5 (AUTHOR), Markus, P.6 (AUTHOR), Schumacher, B.7 (AUTHOR), Albers, D.7 (AUTHOR), Rink, A.2,5 (AUTHOR), Rosery, V.1,2 (AUTHOR), Zaun, G.1,2 (AUTHOR), Kostbade, K.1,2 (AUTHOR), Pogorzelski, M.1,2 (AUTHOR), Ting, S.3,8 (AUTHOR), Schmidt, H.2,9 (AUTHOR), Stiens, R.1,2 (AUTHOR), Wiesweg, M.1,2,4 (AUTHOR), Schuler, M.1,2,4 (AUTHOR), Kasper, Stefan1,2,4 (AUTHOR) stefan.kasper-virchow@uk-essen.de, Virchow, I.1,2 (AUTHOR)
Source: Journal of Cancer Research & Clinical Oncology. Nov2023, Vol. 149 Issue 14, p12903-12912. 10p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:01715216
DOI:10.1007/s00432-023-05141-y